Skip to Main Content

Paper Details

A randomized, controlled study of autologous therapy with bone marrow-derived aldehyde dehydrogenase bright cells in patients with critical limb ischemia.
Catheter Cardiovasc Interv
53
2011

Datasets

Release 1.2